1Haffner S, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J ]. N Eng J Med, 1998,339 : 229 - 234.
2Bartnik M, Malmberg K, Hamsten A, et al. Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls[J]. J Intern Med,2004,256:288 - 297.
3Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the euro heart survey on diabetes and the heart[J]. Eur Heart J,2004,25: 1880-1890.
4Hu Da-Yi. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey[J]. Eur Heart J,2006,27: 2573- 2579.
8Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [ J]. Diabet Med, 1998,15 (7) :539 - 553.
9American Diabetes Association, American Academy of Neurology. Consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy [ J ]. Diabetes Care, 1988, 11 ( 7 ) 592 - 597.
10Park JY, Takahara N, Gabriele A, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C acfivafion[J]. Diabetes,2000,49(7):1239-1248.
